Cantor Fitzgerald Starts Tessera Technologies (TSRA) at Buy; Emerging Growth Prospects & Potential Litigation Wins

Cantor Fitzgerald initiates coverage on Tessera Technologies (NASDAQ: TSRA) with a Buy. PT $25.00.

Analyst, Daniel Gelbtuch, said, "Although there are a number of near-term catalysts and potential pitfalls (Micron's (NYSE: MU) license expires on May 22, while Powertech is trying to escape its) in the near term, we believe TSRA shares are already factoring in a dire scenario."

"Meanwhile, we believe Tessera is on the cusp of: 1) Numerous emerging growth vectors with bright prospects (MEMS autofocus actuators for cameraphones, 3D semiconductor technology); and 2) potentially lucrative litigation victories (against Amkor and QUALCOMM (Nasdaq: QCOM) / AMD (NYSE: AMD) / Freescale (NYSE: FSL)).

For an analyst ratings summary and ratings history on Tessera Technologies click here. For more ratings news on Tessera Technologies click here.

Shares of Tessera Technologies closed at $17.03 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Cantor Fitzgerald Starts Nuvation Bio Inc (NUVB) at Overweight
• William Blair Starts Tandem Diabetes Care (TNDM) at Outperform
• Cantor Fitzgerald Starts Milestone Pharmaceuticals (MIST) at Overweight